2016
DOI: 10.1002/adsc.201600903
|View full text |Cite
|
Sign up to set email alerts
|

Third‐Generation Amino Acid Furanoside‐Based Ligands from d‐Mannose for the Asymmetric Transfer Hydrogenation of Ketones: Catalysts with an Exceptionally Wide Substrate Scope

Abstract: A modular ligand library of α‐amino acid hydroxyamides and thioamides was prepared from 10 different N‐tert‐butyloxycarbonyl‐protected α‐amino acids and three different amino alcohols derived from 2,3‐O‐isopropylidene‐α‐d‐mannofuranoside. The ligand library was evaluated in the half‐sandwich ruthenium‐ and rhodium‐catalyzed asymmetric transfer hydrogenation of a wide array of ketone substrates, including simple as well as sterically demanding aryl alkyl ketones, aryl fluoroalkyl ketones, heteroaromatic alkyl k… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
16
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
5
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 24 publications
(16 citation statements)
references
References 109 publications
0
16
0
Order By: Relevance
“…In spite of the loss of p-cymene moiety, the mechanism of ATH probably involved, also in this case, a classical catalytic cycle. [37][38][39][40] Taking into consideration the differences in both structural coordination mode, our complexes resulted less active and straightly less stereoselective in comparison with other similar catalytic systems reported in literature. 16,35,[41][42] In those systems better results might depend on the presence of an additive in formation of bimetallic 6-membered transition state or in alternative on the presence of an additional phosphine ligand known for reducing the acidity of metal center that favors the hydride transfer.…”
Section: N-(3r4r)-3-[(s)-2-(aminomethyl)pyrrolidin-1-yl]-1-benzylpipmentioning
confidence: 58%
“…In spite of the loss of p-cymene moiety, the mechanism of ATH probably involved, also in this case, a classical catalytic cycle. [37][38][39][40] Taking into consideration the differences in both structural coordination mode, our complexes resulted less active and straightly less stereoselective in comparison with other similar catalytic systems reported in literature. 16,35,[41][42] In those systems better results might depend on the presence of an additive in formation of bimetallic 6-membered transition state or in alternative on the presence of an additional phosphine ligand known for reducing the acidity of metal center that favors the hydride transfer.…”
Section: N-(3r4r)-3-[(s)-2-(aminomethyl)pyrrolidin-1-yl]-1-benzylpipmentioning
confidence: 58%
“…Performing the reaction with bisphosphine ligand 11, we observed in all cases poor enantioselectivity and poor to excellent conversion (Table 1, entries [22][23][24][25][26]. We determined poor results under the catalysis of bisphosphine ligand 12 except chemical yields of the reaction treating with AcOK ( Table 1, entries [27][28][29][30][31].…”
Section: -12mentioning
confidence: 88%
“…[21][22][23][24][25][26][27] The asymmetric transfer hydrogenation (ATH) or reduction of ketones allows the production of a large number of useful chiral alcohols that are ubiquitous in nature and are in great demand for flavors and fragrances, for pharmaceuticals, and for agrochemicals. [28][29][30][31][32][33][34][35] Apart from some procedures, ATH includes some interesting advantages such as using environmentally friendly solvents, low catalyst loading, safe application and volatile byproducts. Consequently, it can be easily applied to industrial processes.…”
Section: Introductionmentioning
confidence: 99%
“…10 To date, many chemical catalysts have been used for asymmetric reduction of 1-tetralone (1) and its derivatives, such as iridiumcatalyzed ligands, oxazaborolidine, amino acid-based ligands, and lutidine-based ligands. [11][12][13][14][15] In the literature, various chemical catalysts were tested for asymmetric reduction of substrate 1. However, to our knowledge, the use of biocatalyst for reduction of 1 has limited.…”
Section: Introductionmentioning
confidence: 99%